DatAIMed is a company headquartered in Italy. Its most recent tracked round is Seed.
DatAIMed provides an AI-powered platform that helps healthcare professionals find, synthesize, and apply scientific evidence for clinical practice by searching and summarizing medical literature. The product offers evidence synthesis, clinical decision support, and educational resources for clinicians.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.